Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 296
Bulletin Date: 23/07/21
Review Date: September 2023
Botulinum Toxin A for treating masseteric hypertrophy and Temporomandibular Joint (TMJ) Disorders in adults aged 18 and over
To support the East of England Priorities Advisory Committee bulletin and Recommendations.
Formulary status : Red – Specialist use only , no GP prescribing
(click View Bulletin PDF below to access the full bulletin).